Fabrizio Romano

Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA.

Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process.

IOLTECH SA Designs, manufactures, and distributes intraocular lenses for medical and surgical applications. The firm offers ocular implants, ocular surgical implements, and pharmaceutical ophthalmic care products to remedy a variety of eye and vision-related problems for people. IOLTECH provides services for the treatment of common problems like cataracts, myopia, hyperopia, and macular degeneration. The company was founded in 1990 by Philippe Tourrette and is headquartered in Perigny, France.

Floreane Medical Implants SA designs, manufactures, and markets surgical implants. The firm's products include Uretex, Parietex, Pariefix, and Prevadh. The company was founded in 1991 and is headquartered in Trevoux, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

CEA Investissement SA (CEA-I), formerly known as CEA Valorisation, is the corporate venture arm and a wholly-owned subsidiary of CEA-Commissariat à l'Energie Atomique, which is the French governmental agency in charge of civilian and defense nuclear research. CEA-I was established in 1999 and is located in Grenoble, a large city in the southeast of France. CEA-I manages a portfolio of direct participations in high-technology companies. The firm also provides services related to IP protection for research done at CEA, by other public research entities or within private companies.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden.

CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France.

Nexess SA provides safety and security solutions. The firm specializes in tags, software, traceability, metrology, tools management, sensitive products, aeronautic, aerospace, nuclear energy, security, harsh environment, smart cabinet, and connected objects. The company was founded by Frederic Galtier in 2008 and is headquartered in Mougins, France.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

VALKEE Oy develops and manufactures health devices. Its flagship product Valkee is a pocket-sized light therapy device that channels bright light via the ear canals into the brain that has beneficial effects on mood and wellbeing of people. The firm is carrying out additional tests and studies concerning the effects of bright light on cognitive and physical performance and jet lag. The company was founded by Juuso Samuel Nissilä and Antti Aunio in 2007 and is headquartered in Oulu, Finland.

ETHERA SA provides diagnostic kits for indoor air pollution. It also develops solutions for measurement of chemical pollutants in the indoor air, especially for toxic volatile organic compounds. The firm's products include Profil'air modules, Profil'air sensors and Profil'air accessories. The company was founded by Yves Bigay, Thu-Hoa Tran-Thi and Sylvain Colomb in 2010 and is headquartered in Crolles, France.

SymbioFCell SA manufactures and industrializes hydrogen fuel systems. It also engages in the development, assembly and integration of its fuel systems. The firm’s product applications include industrial and automotive embarkation, such as short- and mid-range trucks, industrial and specialized vehicles, buses, trams, ferries and barges. The company was founded by Fabio Ferrari in 2010 and is headquartered in Grenoble, France.

Multix SA manufactures spectrometric X-ray. The firm designs, produces and sells advanced spectrometric X-ray detectors, used for the identification of materials in general, non-destructive testing and the detection of explosives in luggage and packages in particular. The company was founded by Jacques Doremus and Patrick Radisson in 2010 and is headquartered in Neuilly-sur-Seine, France.

Nanomakers SA designs and manufactures silicon carbide nanopowders. It offers increase in mechanical and chemical performance for different industrial equipments and materials such as buildings, aeronautics, space, nuclear, automotive and semiconductors. The company was founded by François Tenegal in January 2010 and is headquartered in Ramboillet, France.

Robotiques 3 Dimensions SA specializes in the design and manufacture of collaborative robots. These systems are called cobots otherwise. These devices allow for industry sharing of roles on a workstation: the human and the specific smart move at cobot efforts and vibration. The company was founded by Serge Jean Grygorowicz in 2001 and is headquartered in Moneteau, France.

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

CarThera SAS develops ultrasound based medical devices to treat brain disorders. The firm offers SonoProbe and SonoCloud. The company was founded by Alexandre Carpentier on February 8, 2010 and is headquartered in Paris, France.

Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France.

Krono-Safe SA provides software solutions for the development of embedded systems. It offers embedded operating systems for critical industrial applications such as automotive, aerospace, rail, energy and medical. The company was founded by Damien Chabrol and Didier Roux in 2011 and is headquartered in Orsay, France.

Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.

NAWATechnologies SA engages in developing and industrialising electrode material that combines nano and clean technologies. The firm’s products include NAWACAP, a new generation of ultra rapid carbon batteries based on the principle of supercapacitors; and NawaTECH, a technological platform for custom-made solutions. The company was founded by Pascal Boulanger and Ludovic Eveillard in April 2013 and is headquartered in Rousset Cedex, France.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

Advanced Magnetic Interaction, AMI SAS develops and markets graphic tablets. Its tablets are designed to scan the sketches, drawings and notes taken using a pen incorporating a magnetic ring. The firm’s products have multiple applications such as games and 3D animations. The company was founded by Timothee Jobert, Jean-Luc Vallejo and Tristan Hautson in February 2014 and is headquartered in Saint Martin d'Hères, France.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France.

UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

Diabeloop SAS develops an electronic artificial pancreas for patients suffering from diabetes 1 in order to reduce hypoglycemia. The company was founded on March 24, 2015 and is headquartered in Grenoble, France.

Supernova Invest SAS (Supernova Invest) is an independent venture capital firm headquartered in France. Founded in 1999, the company has offices in Paris and Grenoble, France.

LXRepair is a life science company that develops multiplex high value tests to characterize cellular DNA Repair Enzymatic Status. Its services include DNA repair signature, clinical partnership, and screening assay service. The company was founded by Sylvie Sauvaigo and is headquartered in Grenoble, France.

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France.

NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès.

M2care SAS is based in Lyon, France. The French company is engaged entrepreneurs in the healthcare sector. The company makes investments in human and financial value to co-found, co-operate, and co-develop innovative projects until they reach the patient. M2care SAS is a company founded in 2017.

Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then.

Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.

Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation.